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Study 1 Abstract 
 The Multidimensional Daily Diary of fatigue-fibromyalgia - 17 (MDF-fibro-17) 
instrument explores and evaluates the different components of fibromyalgia syndrome-
related fatigue. Current study examined the factor structure of the MDF-fibro-17 so that 
it is possible to understand the general complexity of how fatigue directly affects 
individuals with this syndrome. Additionally, a cross-cultural analysis was carried out 
between a sample of Portuguese and Brazilian patients. Confirmatory Factor Analysis 
was used to examine the psychometric properties, as well as the measures invariance 
between the samples of these two cultures. In total, 209 Portuguese women aged 
between 21 and 75 years (M = 47.44; SD = 10.73) and 429 Brazilians women, aged 16 to 
77 years (M = 46.51; SD = 9.24) participated in this study. The results revealed that the 
measurement model provided an acceptable fit to the data in both Portuguese and 
Brazilian samples, also displaying convergent and discriminant validity. In addition, the 
model showed acceptable internal consistency and was invariant between cultures. All 
in all, the MDF-fibro-17 can be applied to patients with fibromyalgia syndrome in both 
Portuguese and Brazilian women to measure which domain of fatigue it has the greatest 
impact; thus, clarifying the possible treatments to this disease. 
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Study 2 Abstract 
Fibromyalgia syndrome (FM) is one of the most common causes of chronic 
musculoskeletal pain and is widespread in the mid-adult population (between 30 and 50 
years old), affecting mainly female people. It is estimated that 2% to 4% of the world 
population suffers from FM symptoms. As it is a chronic syndrome, younger patients, 
who have a positive diagnosis for FM, report a fear that their symptoms will worsen as 
they get older. So the aims of this study, is to verify the differences in the perceptions of 
fatigue between patients with FM in Brazil and in Portugal, as well as to evaluate and 
verify if there are differences in the perceptions of fatigue between the ages of the patients 
and the time when they were diagnosed. In total, 209 Portuguese women aged between 
21 and 75 years (M = 47.44; SD = 10.73) and 429 Brazilians women, aged 16 to 77 years 
(M = 46.51; SD = 9.24) participated in this study. The results revealed that Brazilian 
women have a greater perception of fatigue than Portuguese women. In addition, the 
model showed that regardless of the time of diagnosis and age of the patient, fatigue and 
its components remain relevant. The verification of the perception of the components of 
fatigue in comparison between cultures, and through the age and time of diagnosis bring 
significant contributions to the literature in the scope of FM. 
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Fibromyalgia syndrome (FM) is a chronic condition that affects 2% to 4% of the world 
population, with middle-aged women (between 30 and 50 years old) being the main 
carriers of this disorder (Assumpcao et al., 2018; Saral et al., 2016). The quality of life of 
these women is substantially compromised, as it causes a series of disorders, such as 
musculoskeletal pain without external stimuli, chronic fatigue syndrome, decreased 
maximum muscle strength and some psychological problems such as sleep disorders, 
anxiety and depression (Busch et al., 2011; Chang et al., 2019). 
Although the origin of FM is not yet fully understood, it is currently known that there is 
a relationship with the nervous system and neurochemical imbalances, for the 
appearance of the first symptoms of this syndrome (Demirbag & Bulut, 2018). The 
association between the nervous system and neurochemical imbalances ends up making 
the pharmacological treatment generic and acts only on the signs and symptoms 
presented by the patient during crises (Demirbag & Bulut, 2018). The signs and 
symptoms of FM vary from individual to individual; however, excessive fatigue, sleep 
problems, depressive symptoms, anxiety, irritability, generalized pain and pain at 
specific points known as "tender points" are the most reported by people with this 
syndrome (O'Dwyer et al., 2019; Queiroz, 2013). 
Another factor that makes treatment difficult is the lack of evaluation and means for 
diagnosing FM, as the individual must reach certain values in two questionnaires, one 
focusing on the severity of pain and the other on generalized muscle pain (Wolfe et al., 
2010). After combining these two criteria, without changing the intensity of the 
symptoms for more than three months and without any other medical condition that 
justifies these symptoms, we can diagnose individuals with this syndrome (Bernard et 
al., 2018). Despite the intense pain that individuals feel during everyday life, fatigue is 
one of the main disabling factors for patients with FM and is used as a reference when 
asked about their well-being and quality of life (Arnold et al., 2011; Hudson et al., 2009; 
Morris et al., 2017). 
Therefore, this work aims to translate and validate this questionnaire for the Portuguese 
and Brazilian population, and thus to verify the differences between the perception of 





the effect of the issues addressed; 2) Check the invariance according to the cultures 
analyzed; 3) Analyze whether age influences the feeling of fatigue; 4) Check if the 












Study 1: The Multidimensional daily diary of 
fatigue-fibromyalgia 17 items (MDF-fibro-17): 
evidence from validity, reliability and 
transcultural invariance between Portugal 
and Brazil  
Introduction 
Fatigue is widely known and understood, because it is a natural response of the body to 
some sort of physical stress, but it can also be a sign of possible physical and mental 
disorders (Finsterer & Mahjoub, 2014; Ulus et al., 2019). In healthy individuals, fatigue 
is a physiological reaction to prolonged intense activity to which the body can easily 
recover with rest which normally does not interfere with their day-to-day activities. In 
individuals who have some type of disease (e.g., FM, anemia, hypothyroidism, Chronic 
Obstructive Pulmonary Disease) or physical limitations, symptoms of fatigue have a 
different meaning when compared to healthy individuals (Finsterer & Mahjoub, 2014). 
Specifically, FM patients report that their fatigue is characterized by excessive physical 
tiredness and that it is usually not eased after hours of sleep or rest, which ends up 
making it the biggest obstacle to overcome physical inactivity and to perform daily tasks 
(Arnold et al., 2011; Finsterer & Mahjoub, 2014; Humphrey et al., 2010). 
As described earlier on pain, fatigue is also measured through a self-reported measure, 
in which the patients make a critical and subjective analysis of their perception of this 
symptom. One of the most used instruments is the Multidimensional Fatigue Inventory 
(MFI), which has been used in the past to measure subjective fatigue (Smets et al., 1995). 
While the MFI has displayed utility in identifying symptoms of fatigue in several chronic 
patients, it has not been tested and validated for FM patients, making it ineffective for a 
deep understanding of fatigue individuals experience by this clinical condition 
(Humphrey et al., 2010). So due to this lack of validated instruments on measuring 
fatigue, specific for FM patients, the Multidimensional daily diary of fatigue-fibromyalgia 
- 17 (MDF-fibro-17) was develop (Li et al., 2017; Morris et al., 2017). MDF-fibro-17 was 





could be possible to understand the general complexity of how fatigue directly affects 
people with this syndrome (Li et al., 2017). The questionnaire comprises 17 items that 
measure five dimensions of FM: i) Global Experience; ii) Cognitive Fatigue; iii) Physical 
Fatigue; iv) Motivation; and, v) Impact on Function. This subdivision is due to the 
recognition and acceptance of fatigue as a multidimensional-related factor and by the 
need for investigation and treatment for each specific dimension of fatigue (Morris et al., 
2017). For a better understanding of each subscale, a definition is presented. 
Global Fatigue Experience 
This domain is used to capture and demonstrate certain general points of fatigue, which 
are not suitable for other more specific domains as FM carriers use a variety of terms to 
speak and describe their fatigue. This dimension presents itself as paramount, since 
several global terms have been used involving important and comprehensive elements to 
capture the experience of fatigue in a global manner (Arnold et al., 2008; Morris et al., 
2017). 
Cognitive Fatigue 
FM patients report that their fatigue affects them both physically and mentally(Dailey et 
al., 2015; Morris et al., 2017). With this, there are cognitive limitations that are described 
by these people, where they describe mental tiredness, which ends up impacting their 
concentration to perform tasks, to think clearly or remember something. For this reason, 
this domain has the role of measuring how much fatigue affects and limits the cognition 
of the patients of the disease (Dailey et al., 2015; Morris et al., 2017). 
Physical Fatigue 
People with FM report that physical fatigue is one of the biggest barriers and problems,  
reported by muscle weakness and a feeling of heaviness in their body (Dailey et al., 2015; 
Morris et al., 2017). Therefore, this domain has the function of assessing how much this 
physical fatigue affects patients with FM (Dailey et al., 2015; Morris et al., 2017). 
Motivation 
Patients with FM describe motivation as a direct and integral factor than fatigue, as they 
have severe difficulties to motivate themselves causing a greater effort to perform any 





is used to check how much motivation (or lack) hinders FM carriers to act upon a given 
activity or behavior (Humphrey et al., 2010; Morris et al., 2017). 
Impact on Function 
One of the main issues that FM patients describe is that fatigue influences their 
functional capacity, even in their daily activities. Therefore, this domain has the function 
of evaluating, in a specific manner, how fatigue affects and disturbs patients affected by 
FM in the performance of their basic functions (Humphrey et al., 2010; Morris et al., 
2017). 
Past Limitations and Current Research 
Previous studies have shown that fatigue is the main symptom reported by patients, 
when asked what most affects your general health and overall perception of the disease 
(Arnold et al., 2008; Hudson et al., 2009). Even though this is a major impact factor in 
this disease, fatigue is not always included and evaluated in clinical FM research (Mease 
et al., 2007; Morris et al., 2017). One of the possible reasons why this happens is because 
it does not have a specific fatigue measurement tool for patients with FM, which means 
that the results end up not being accurate or inconclusive (Mease et al., 2009). For this 
reason, the MDF-fibro-17 was developed to capture aspects of global fatigue and its 
constructs (Morris et al., 2017). To the best of our knowledge, the original research of 
MDF-fibro-17 has only been carried out with only one sample considering FM patients 
with similar socio demographic characteristics. Thus, the MDF-fibro-17 lacks a cultural 
variance, since multigroup analyzes allow to assess the equivalence of the measurement 
model between groups with different characteristics and to demonstrate whether there 
is a difference between the perception of the disease (Sass, 2011). So, the process of cross-
cultural adaptations is essential when the instrument is validated for a specific type of 
population but being used in different cultures (Cid et al., 2016; Mease et al., 2007; 
Mease et al., 2009; Sass, 2011). 
Cross-cultural studies must have a substantial sample size, an adequate model 
specification, and that item meanings do not suffer differences between the groups with 
different characteristics (Sass, 2011). Another important factor in intercultural studies is 
to verify the possible difference in the perception of certain points of the same factors 





2020; Vlachopoulos et al., 2013). In Portugal, the prevalence of the disease is between 
1.3 to 2.1% of the population, that is, more than 200,000 adults have been diagnosed 
(EpiReuma, 2013). Women are the most affected by FM, with a proportion of six cases 
to just one case among males (Gomes & Campos, 2010). The study by Branco et al. (2010) 
shows that Portugal presents more FM carriers and great parameters in the 
questionnaire for pain arising when compared to other Western European countries 
(Spain, France, Germany and Italy). In Brazil, it is estimated that 2% of the population 
has a positive diagnosis for FM, that is, approximately 4.2 million Brazilians suffer from 
this disease, with the proportion of every 1 man with a positive diagnosis, there are 5.5 
women (Souza & Perissinotti, 2018). These findings support previous mentioned 
literature that this disease largely affects women compared to men.  
Therefore, considering the dynamic and continuous process of validating the instrument, 
the present study performed the translation of MDF-fibro-17 for a sample of Portuguese 
and Brazilian patients with FM. 
Several authors have described the importance of performing the measurement 
invariance test between groups to determine whether they can be applied to different 
groups with different characteristics (Byrne, 2010; Cheung & Rensvold, 2002). So, for 









Two independent samples were collected for the present study. Sample 1 consisted of a 
total of 290 Portuguese women aged between 21 and 75 years (M = 47.44; SD = 10.73) 
who were invited to participate in the study. The Portuguese participants were diagnosed 
with FM on average 7.71 ± 6.04 years. Sample consisted of data from 429 Brazilians 
women aged between 16 and 77 years (M = 46.51; SD = 9.24). The Brazilian individuals 
were diagnosed with FM on average 7.71 ± 6.04 years. 
Procedure: Data Collection 
After obtaining the responses from each panel of specialist, we contacted the doctors 
responsible for the specific FM groups on Facebook, so that they could administer and 
forward the questionnaires to the members of the group who had this disease. All 
individuals participated voluntarily in this study. Participants did not receive any 
monetary reward for their contribution. Before data collection, ethical approval was 
obtained from the ethic and scientific board of the Research Centre in Sport, Health and 
Human Development (CIDESD) under the reference UID04045/2020, Portugal. 
Current study was conducted according to the Helsinki declaration and its latter 
amendments. 
Instrument 
The MDF-fibro-17 (Morris, et al., 2017) was used to measure the different components 
of FM-related fatigue. This 17-items consists of five subscales: global fatigue experience 
(four items; e.g., “How severe was your fatigue today”); Physical fatigue (three items; 
e.g., “How weak did your muscles feel today”); Cognitive fatigue (four items; e.g., “How 
difficult was it to concentrate because you were tired today?”); Motivation (three items; 
e.g., “How much of an effort was it to do things today?”); and, Impact on function (three 
items; e.g., “Did you do things more slowly because you were tired today?”). 
Participants responded to each item using a 10-point scale ranging from 0 (“not at all”) 
to 10 (“extremely”). Higher scores indicated greater fatigue severity. Previous studies 





Procedures: Translation of the questionnaire 
The translation of the MDF-fibro-17 from English to Portuguese was done using the 
committee approach methodology (see Brislin, 1980) as suggested by Banville et al 
(2000). The process includes five stages:   
1) Preliminary Translation: The first stage was carried out by researchers with the help 
of three bilingual (English-Portuguese) teachers where the original questionnaire was 
translated into Portuguese which resulted in its first draft; 
2) First Evaluation Panel: An analysis of the initial version of the MDF-fibro-17 
Portuguese version was carried out individually by specialists from different areas, such 
as two medical doctors specialized in FM and four research specialists in psychometric 
validations. Items received slight syntax and semantic modifications as proposed by their 
revisions and feedback; 
3) Second Evaluation Panel: A revised version of the questionnaire was sent again for a 
new evaluation to another panel formed by three other specialists in the same categories 
as the previous ones (i.e., two medical doctors and four research specialists in 
psychometric validations). This panel examined all the items encompassed in the 
questionnaire and pointed out some small changes, which were accordingly accepted and 
modified so that a new version could be used for preliminary testing; 
4) Pilot study: The revised questionnaire was answered by a group of 50 FM patients (22 
from Portugal and 28 from Brazil), to determine if all items were properly clear and 
understandable;  
5) Final revision: two Portuguese and two Brazilian teachers revised the final translated 
version of the MDF-fibro-17 to identify possible syntax, spelling, and grammar issues. 
Statistical analysis 
Descriptive statistics (means and standard deviation), as well as bivariate correlation, 
were calculated for all variables under analysis. For test-retest reliability evaluation, 40 
Portuguese and Brazilian subjects were considered as recommended by Banville et al. 
(Banville et al., 2000). Based on the probability theory, a sample size of n = 30 





recommended (Hair et al, 2019). The time between questionnaire administrations was 
four weeks as suggested by Banville et al (Banville et al., 2000). 
For model assessment, a Confirmatory Factor Analysis (CFA) using the maximum 
likelihood estimator in AMOS 23.0 (Arbuckle, 2014) was conducted. Measurement 
model adequacy was verified by the traditional absolute and incremental indices, 
namely: Comparative Fit Index (CFI), Tucker-Lewis Index (TLI), Standard Mean Root 
Square Residual (SRMR), and Root Mean Square Error of Approximation (RMSEA) with 
a confidence interval of 90%. For model adequacy, the following cutoffs suggested by 
several authors (Byrne, 2016; Marsh, Hau, & Wen, 2004) were considered: CFI and TLI 
≥ 0.90, SRMR and RMSEA ≤ 0.8. 
Internal consistency was examined through composite reliability coefficients adopting 
≥.70 as cutoff (Hair, Black, & Anderson, 2014). Average Variance Extracted (AVE) was 
calculated to examine convergent validity accepting values >.50 as proposed by several 
authors (Kline, 2016; Hair et al., 2019). Discriminant validity was achieved when AVE 
values were greater than the squared correlation across constructs of the measurement 
model (Hair et al., 2014). 
Multigroup analysis 
Several authors (Chen, 2007; Cheung & Rensvold, 2002) have shown that measurement 
invariance is a crucial analysis to determine whether certain measurements can be 
applied to different groups with different characteristics. A multigroup analysis between 
the Portuguese and Brazilian samples was conducted based on author recommendations 
(Byrne, 2016; Chen, 2007; Cheung & Rensvold, 2002). Specifically, two criteria had to 
be met to achieve measurement invariance: (1) the measurement model should provide 
acceptable fit in each sample; (2) configural, metric, scalar and residual invariance 
criteria should be respected. In this study, invariance criteria were evaluated considering 
different cutoffs, specifically: configural invariance, differences in CFI(ΔCFI) should be 
less than .01 (Cheung & Rensvold, 2002); for metric invariance,  differences in CFI 
(ΔCFI) should be less than .01, differences in SRMR (∆SRMR) should be less than .030 
and differences in RMSEA (∆RMSEA) should be less than .015; and, for scalar 
invariance, ∆SRMR should be less than .010, ∆RMSEA should be less than .015 and 








A preliminary inspection of the data showed no missing values or outliers (both 
univariate and multivariate). Skewness and kurtosis values are comprised within cutoffs 
revealing no violation from univariate data distribution. Nevertheless, Mardia’s 
coefficient for multivariate kurtosis exceed the recommended value in all samples 
(Byrne, 2016). Consequently, a Bollen-Stine bootstrap (2000 samples) was performed 
for further analysis (Nevitt & Hancock, 2001). 
Test-retest analysis 
Test-retest analysis showed that the correlations from responses given to each item in 
the first and second administrations of the instrument varied from .72 (Item 14) to .89 
(Item 15) in the Portuguese Sample; and ranged from .71 (Item 16) to .87 (Item 12) in the 
Brazilian Sample. In this regard, acceptable test-retest correlations (>.70) were found 
indicating that the items had a high degree of temporal reliability. For detailed 






Table 1. Test-retest reliability analysis (Portuguese Sample) 
Note. M = Mean; SD = Standard Deviation; r= bivariate correlations; p = level of significance 
 
  
Items M±SD r p Alpha 
Item 1 Pre-Post 7.24±1.62 – 7.38±1.77 .83 <.001 
 
Item 2 Pre-Post 7.24±1.68 – 7.72±1.91 .82 <.001 
 
Item 3 Pre-Post 7.88±1.34 – 7.82±1.56 .86 <.001 
 
Item 4 Pre-Post 7.39±1.71 – 7.74±1.82 .76 <.001 
 
Item 5 Pre-Post 7.48±1.64 – 7.46±2.05 .81 <.001 
 
Item 6 Pre-Post 7.82±1.79 – 8.03±1.86 .80 <.001 
 
Item 7 Pre-Post 7.70±1.55 – 8.00±1.72 .81 <.001 
 
Item 8 Pre-Post 7.06±2.16 – 7.33±2.02 .78 <.001 
 
Item 9 Pre-Post 7.06±2.20 – 6.23±2.04 .76 <.001 
 
Item 10 Pre-Post 7.48±2.03 – 7.69±1.72 .71 <.001 
 
Item 11 Pre-Post 7.27±1.86 – 7.36±1.97 .81 <.001 
 
Item 12 Pre-Post 7.79±1.45 – 7.90±1.68 .84 <.001 
 
Item 13 Pre-Post 7.89±2.05 – 7.67±2.19 .76 <.001 
 
Item 14 Pre-Post 7.45±2.18 – 7.56±2.43 .72 <.001 
 
Item 15 Pre-Post 7.64±1.64 – 7.77±1.95 .89 <.001 
 
Item 16 Pre-Post 7.64±1.95 – 7.51±2.45 .74 <.001 
 
Item 17 Pre-Post 7.85±.1.73 – 7.82±2.32 .86 <.001 
 
Global Fatigue Experience Pre-Post 7.44±.1.47 – 7.67±1.58 .87 <.001 0.77 - 0.78 
Physical Fatigue Pre-Post 7.67±1.47 – 7.83±1.75 .76 <.001 0.80 - 0.77 
Cognitive Fatigue Pre-Post 7.22±1.94 – 7.40±1.83 .84 <.001 0.81 - 0.83 
Motivation Pre-Post 7.70±1.61 – 7.71±1.74 .81 <.001 0.82 - 0.81 





Table 2. Test-retest reliability analysis (Brazilian Sample) 
Note. M = Mean; SD = Standard Deviation; r= bivariate correlations; p = level of significance 
  
  M±SD r p Alpha 
Item 1 Pre-Post 6.39±2.43 – 7.03±2.34 .80 <.001 
 
Item 2 Pre-Post 6.70±2.16 – 7.32±2.17 .86 <.001 
 
Item 3 Pre-Post 7.04±2.08 – 7.46±2.18 .80 <.001 
 
Item 4 Pre-Post 7.00±2.52 – 7.59±2.41 .77 <.001 
 
Item 5 Pre-Post 7.43±2.31 – 7.78±2.12 .84 <.001 
 
Item 6 Pre-Post 7.78±2.28 – 8.05±2.05 .83 <.001 
 
Item 7 Pre-Post 7.74±2.09 – 8.11±1.98 .84 <.001 
 
Item 8 Pre-Post 6.70±2.34 – 7.51±2.24 .80 <.001 
 
Item 9 Pre-Post 6.65±2.34 – 7.38±2.67 .79 <.001 
 
Item 10 Pre-Post 6.17±2.64 – 7.14±2.58 .72 <.001 
 
Item 11 Pre-Post 6.43±2.57 – 7.19±2.45 .83 <.001 
 
Item 12 Pre-Post 7.39±2.25 – 7.89±2.12 .87 <.001 
 
Item 13 Pre-Post 7.43±1.95 – 7.89±2.05 .75 <.001 
 
Item 14 Pre-Post 7.22±2.76 – 7.54±2.56 .73 <.001 
 
Item 15 Pre-Post 7.35±1.99 – 7.95±1.94 .88 <.001 
 
Item 16 Pre-Post 7.00±2.45 – 7.76±2.35 .71 <.001 
 
Item 17 Pre-Post 7.26±.2.40 – 7.92±2.29 .84 <.001 
 
Global Fatigue Experience Pre-Post 6.78±.2.06 – 7.35±2.05 .88 <.001 0.76 - 0.74 
Physical Fatigue Pre-Post 7.65±2.10 – 7.98±1.44 .79 <.001 0.81 - 0.79 
Cognitive Fatigue Pre-Post 6.49±2.37 – 7.30±2.30 .86 <.001 0.79 - 0.78 
Motivation Pre-Post 7.35±2.10 – 7.77±2.03 .85 <.001 0.80 - 0.81 





Descriptive Statistics, Internal Consistency, and 
Convergent and Discriminant Validity 
 
Table 3 presents descriptive statistics, internal consistency estimates, AVE scores, and 
bivariate correlations for all factor under analysis in both the Portuguese and Brazilian 
samples. Results showed that individuals from both countries presented a high mean 
(i.e., above midpoint) values in all factors. Moreover, there is evidence that all factors 
have adequate internal consistency values, and convergent validity criteria was respected 
in both samples. Discriminant validity was confirmed for 8 of the 10 possible 
comparisons in the Portuguese sample. Only the interaction between Global Fatigue 
Experience and Physical Fatigue, and between motivation and impact on function did 
not displayed discriminant validity. In the Brazilian sample, discriminant validity was 
confirmed for 7 of the 10. Discriminant validity was not achieved in the following 
interactions: Global Fatigue Experience and Physical Fatigue; between Global Fatigue 
Experience and motivation; between physical fatigue and motivation; and, between 
cognitive fatigue and motivation. 
 
Table 3. Descriptive statistics, composite Reliability coefficients, AVE scores and correlations 
 M SD CR AVE     r2  
Portuguese Sample      1 2 3 4 5 
1 - Global Fatigue Experience 7.25 1.58 .93 .77 
 
1 - - - - 
2 - Physical Fatigue 7.49 1.64 .92 .80 
 
.83 1 - - - 
3 - Cognitive Fatigue 7.20 1.85 .95 .84 
 
.55 .59 1 - - 
4 - Motivation 7.50 1.70 .88 .72 
 
.69 .71 .65 1 - 
5 - Impact on Function 7.45 1.83 .92 .80 
 
.67 .65 .65 .89 1 
Brazilian Sample 
          
1 - Global Fatigue Experience 7.72 1.73 .92 .73 
 
1 - - - - 
2 - Physical Fatigue 8.22 1.58 .89 .73 
 
.80 1 - - - 
3 - Cognitive Fatigue 7.88 1.82 .95 .83 
 
.63 .58 1 - - 
4 - Motivation 8.19 1.71 .84 .64 
 
.67 .72 .70 1 - 
5 - Impact on Function 8.26 1.80 .92 .80 
 
.55 .70 .61 .80 1 
Note. M = Mean; SD = Standard Deviation; CR = Composite Reliability; AVE = Average Variance Extracted; 





Confirmatory Factor Analysis 
Results from the measurement models in each group are displayed in Table 4. The 
current study showed that the CFA model specification provided an acceptable fit in both 
the Portuguese and Brazilian versions of the original version. In addition, items 
presented factor loadings equal to/ or greater than 0.50, explaining at least 25% of the 
variance of the latent factor. For detailed information of the factor structure of the model 
see Figure 1 and 2 (Portuguese and Brazilian samples, respectively).  
Table 4. Goodness-of-fit indexes of the Portuguese and Brazilian versions and original model of MDF-
fibro-17 
Note. χ² = chi-squared; df = degrees of freedom; B-S p = Bollen-Stine bootstrap; CFI = Comparative Fit 
Index; TLI = Tucker-Lewis Index; SRMR = Standardized Root Mean Square Residual; RMSEA = Root 
Mean Squared Error of Approximation; CI = Confidence Interval; PT = Portugal; BR = Brazil 
  
Models χ2 df B-S p CFI TLI SRMR RMSEA RMSEA 90% CI 
MDF-fibro-17- PT version 369 381 109 >.001 .954 .943 .030 .080 .076-.082 
MDF-fibro-17- BR version 381.48 109 .002 .962 .953 .026 .076 .068-.085 




















To test measurement invariance between cultures, the configural model was compared 
with the metric model, the scalar model, and the residual model. Multigroup analysis 
(see Table 5) revealed that the differences in CFI, RMSEA, and SRMR between configural 
model and nested models were below cutoffs. These analyses suggest that invariance 
remained stable with each subsequent parameter restraint, displaying that the model 
does not differ across cultures due to the sufficient model fit in each model (i.e., metric, 
scalar, and residual). 
Table 5. Goodness-of-Fit Indexes of the multigroup analysis between Portugal and Brazil 
Note. χ² = chi-squared; df = degrees of freedom; ∆χ² = differences in chi-squared value; ∆df = differences 
in the degrees of freedom; CFI = Comparative Fit Index; ∆CFI = differences in the value of the 
Comparative Fit Index; RMSEA= root mean square error of approximation; ∆RMSEA= differences in root 
mean square error of approximation value; SRMR = standardized root mean square residual; ∆SRMR= 
difference in standardized root mean square residual. 
 
 χ2 df Δ χ2 Δdf p CFI ΔCFI RMSEA ΔRMSEA SRMR ΔSRMR 
Configural Invariance  750,938 218 - - - .959 - .058 - .0301 
 
Metric Invariance  769,693 230 18,755 12 .095 .958 .001 .057 .001 .0292 .009 
Scale Invariance  817,251 245 66,313 27 <.001 .956 .003 .057 .001 .0340 .004 






The purpose of the present study was to address an existing gap in the literature by 
developing and testing the MDF-fibro-17 in a sample of Portuguese and Brazilian 
patients, different from the original instrument in English, an instrument designed to 
measure five dimensions of FM. Additionally, a cross-cultural invariance between 
Portugal and Brazil samples was analyzed. The development and testing of measures 
have become an important focus of research among scholars and medical doctors. 
Overall, the findings support the utility of the MDF-fibro-17 as a method to provide 
reliable assessment of FM symptoms/dimensions in individuals from two distinct 
cultures. 
Factorial Validity of the MDF-Fibro-17 
The present results suggest that the proposed five-factor solution assess the dimensions 
of fatigue according to the original model/instrument. Specifically, current findings 
provide support for the psychometric proprieties of the MDF-fibro-17 in the Portuguese 
and Brazilian samples. Item correlations ranged from .71 (Item 10 in the Portuguese 
model and item 16 in the Brazilian version) to .89 (Item 15), as seen in Table 1 and in 
Table 2. Thus, findings provide acceptable test-retest correlations (> .70), indicating that 
MDF-Fibro-17 had a high degree of temporal reliability, in both versions. Regarding 
internal consistency, the results of the present research showed that composite reliability 
coefficients showed acceptable internal consistency (Hair et al., 2014). Similar results 
have been reported elsewhere (Li et al., 2017) showing a good degree of reliability of the 
translated versions. Additionally, AVE scores in the present study were above cutoffs, 
achieving convergent validity in all factors in both samples.  
All factorial loadings in the Portuguese adapted 17-item version exhibited acceptable 
factor loadings (>.50) and loaded significantly their respective factors (p<.01), following 
previous assumptions (Byrne, 2010; Hair et al., 2019). The multidimensional structure 
of MDF-Fibro-17 allows scholars and medical doctors to verify with reliable capacity the 
fatigue factor in which the individual is most affected  (Brislin, 1980). These results 
provide further support of the validity of the MDF-fibro-17 in both Portuguese and 
Brazilian samples, as several criteria for acceptable factor structure were respected (Hair 





When analyzing for discriminant validity, some dimensions did not meet the criteria. 
Specifically, the factors between the Experience of Global Fatigue and Physical Fatigue, 
and between Motivation and Impact on Function displayed some issues in the 
Portuguese sample. Looking at the Brazilian sample, the relationship between the Global 
Fatigue Experience and Physical Fatigue can also be verified, but there is also a 
relationship between Physical Fatigue with Motivation and also Cognitive Fatigue with 
Motivation. Current findings were was not showed in the original study Li and colleagues 
(Li et al., 2017) only found discriminant validity issues between motivation and physical 
fatigue. This can demonstrate that different populations, with different cultures, can 
demonstrate different perceptions of fatigue in relation to the disease. Current results 
may also be explained by the differences among cultures. Portuguese native speaking FM 
patients could perceive and experience fatigue more as a global perception, rather than 
specific dimensions as English native speaking FM patients tend to experience. However, 
this is only speculative and more studies with other samples from different cultures are 
warranted to explore the discriminant validity of the factors. Additionally, future studies 
with exploratory models and bifactor specifications are needed to examine the 
dimensionality of the MDF-fibro-17 not only e Portuguese speaking individuals, but also 
on the original scale. All in all, more intercultural studies, like this one, are paramount 
to explore in more detail FM patient perception of fatigue and their characteristics 
(Gomez-Calvente et al., 2015; Seo et al., 2015).  
Measurement invariance 
Regarding measurement invariance of the 17-item model, present findings demonstrate 
the equivalence of the instrument between the two analyzed cultures. Specifically, the 
adapted MDF-fibro-17 Portuguese and Brazilian versions are conceptualized and 
understood in the same manner between these cultures. Considering the premises of 
model invariance analysis, defined in the method section (Byrne, 2010; Cheung & 
Rensvold, 2002), results show that: a) the theoretical model of the MDF-fibro-17 is the 
same for both countries (configural invariance); b) the factorial weight of the items is 
equivalent for both countries (invariance of the measure), that is, each item has the same 
importance regardless of the group; and, c) the results can be compared between the two 
countries using the same questionnaire (scale invariance). (Li et al., 2017). According to 
some authors (Byrne, 2016; Cheung & Rensvold, 2002), residual invariance is optional, 
as it is very difficult to achieve. Thus, there is linguistic equivalence and operational 







The present findings showed that the adapted MDF-Fibro-17 provided acceptable fit to 
both samples and has a great capacity to verify the five components of fatigue in patients 
with FM. However, current findings should be considered in relation to some limitations. 
First, this research did not directly measured whether the participants were currently 
endorsed in therapies or physical activities to control the symptoms resulting from FM. 
This factor can be explored in future research, with control groups to verify the 
effectiveness of certain therapies to improve certain aspects of fatigue in patients with 
this disease. Second, current findings cannot be generalized to other countries or 
contexts, as further research is needed to establish the validity of these scales (i.e., 
Portuguese and Brazilian versions). Specifically, future studies should examine the factor 
structure of the MDF-fibro-17 in other groups with different characteristics. It is worth 
to mention that the 17-item model showed an acceptable fit similar to those results 
reported by previous literature (Li et al., 2017; Morris et al., 2017). This fact shows that 
current Portuguese and Brazilian versions are reliable sources for measuring symptoms 
of fatigue and that current samples interpreted the meaning of each component similarly, 
when compared to the participants in the original study. 
Practical Implications 
The validated MDF-fibro-17 Portuguese and Brazilian versions make significant 
contributions to the literature concerning the measurement of FM patients. The 
instruments complement limited literature examining the factor structure of the MDF-
fibro-17 (Li et al., 2017).In general, the results obtained by this study provide support for 
the validity of the original MDF-Fibro-17 adding new evidence to distinguish FM 
dimensions. The present study reinforces the importance of assessing fatigue in FM 
patients, since it is one of the main issues and limitations in this population. 
All in all, current findings show that MDF-fibro-17 is a relevant, necessary, and sensitive 
multidimensional instrument for detecting clear definitions of fatigue responses. In 
general, this questionnaire has the potential to be a reliable tool for assessing clinical 
results to verify which dimension of fatigue the patient is most precarious or better so 












Study 2: Differences between Brazil and 
Portugal in the perception of fatigue 
components in fibromyalgia in relation to 
age and time of diagnosis 
Introduction 
Fibromyalgia syndrome (FM) is one of the most common causes of chronic 
musculoskeletal pain and is widespread in the mid-adult population (between 30 and 50 
years old), affecting mainly female people (Neumeister & Neumeister, 2020; Saral et al., 
2016).  
It is estimated that between 2% to 4% of the world population suffers from FM symptoms 
(Assumpcao et al., 2018). In Portugal, the prevalence of the disease is 2.1% of the 
population, that is, more than 200,000 people have a positive diagnosis for FM, with the 
proportion that there are 6 women with FM for each man with a positive diagnosis 
(EpiReuma, 2013; Gomes & Campos, 2010). The study by Branco et al (Branco et al., 
2010) shows that Portugal has more FM carriers when compared to other Western 
European countries (Spain, France, Germany and Italy). In Brazil, it is estimated that 2% 
of its population has FM, which represents approximately 4.2 million Brazilians with FM, 
with the proportion that for every 1 man with a positive diagnosis, there are 5.5 women 
(Souza & Perissinotti, 2018).  
Among the main symptoms reported by patients, there are musculoskeletal pain without 
external stimuli, specific places of musculoskeletal sensitivity (also called tender points), 
decreased muscle strength, chronic fatigue syndrome, and psychological adversities such 
as sleep disorders, anxiety and depression (Busch et al., 2011; Chang et al., 2019).  
Although there is no certainty about the origin of FM, it is currently known that there is 
a relationship between the nervous system and neurochemical imbalance, for the 
appearance of the first symptoms of this syndrome (Demirbag & Bulut, 2018). With this, 
FM is a multifactorial health condition, that is, its symptoms worsen or are maintained 
based on the interaction of several factors, being biological, psychological and social 





Due to these multiple factors that FM involves, the pharmacological treatment for this 
disease turns out to be generic, being only taken into account the signs and symptoms 
presented by the patient during crises (Demirbag & Bulut, 2018).  
Another factor that makes the treatment of this disease difficult is the lack of evaluations 
and means for the diagnosis (Branco et al., 2010; Wolfe et al., 2010). For a health 
professional to diagnose FM, the patient must obtain certain values in two 
questionnaires established by the American College of Rheumatology (Branco et al., 
2010; Wolfe et al., 2010). These two questionnaires focus on the severity of the pain the 
patient is feeling, and the other on the intensity of generalized muscle pain (Wolfe et al., 
2010). After combining the results of these two questionnaires and without any change 
in symptom intensity for more than three months, it can be diagnosed that the patient 
has FM (Bernard et al., 2018). However, fatigue is the main symptom, which patients 
report to be the most disabling of the harm caused by FM, thus interfering drastically in 
their well-being and quality of life (Arnold et al., 2011; Branco et al., 2010; Hudson et al., 
2009; Morris et al., 2017). 
Studies show that FM patients show less quality of life when compared to people with 
any other rheumatic disease (Castro, Kitanishi, & Skare, 2011; Letieri et al., 2013). To 
assess the impact of FM on quality of life, the Fibromyalgia Impact Questionnaire (FIQ) 
(Burckhardt, Clark, & Bennett, 1991) is used to assess questions about physical 
dysfunctions, psychological changes and even the professional situation of each person 
(Castro et al., 2011; Letieri et al., 2013).   
Inability to perform work or day-to-day tasks, not fully understanding the symptoms, 
feeling of disability, negative impact on interpersonal relationships, isolation, social 
exclusion and the difficult control of the various symptoms end up leading to a 
deterioration in quality of life and a significant worsening of their health status, both 
physical and mental, which ends up increasing the severity of the disease and its 
symptoms in its carriers (Lobo et al., 2014; McInnis et al., 2015). The study by Ghavidel-
Parsa et al (2015) found that FM patients had the second lowest quality of life, when 
compared to patients of other pathologies and that affect the perception of quality of life 





Difference in FM perception through age and time 
since diagnosis 
As it is a chronic syndrome, younger patients, who have a positive diagnosis for FM, 
report a fear that their symptoms will worsen as they get older (Burckhardt, Clark, & 
Bennett, 2010). However, some studies have evaluated that over the years, the 
symptoms, especially pain, of the studied patients had a decrease in their intensity 
(Granges, Zilko, & Littlejohn, 1994; Kennedy & Felson, 1996). 
This finding was also confirmed by the study conducted by Burckhardt et al (2010), 
where it was found that the group that had older age had lower levels of pain intensity in 
specific locations. Regarding the time of diagnosis, the study developed by Berber et al 
(2005), demonstrated that the longer the time of diagnosis, the more the patients had 
better levels of quality of life and lower scores on the pain scale. 
However, to best of our knowledge no studies were found in the literature that 
specifically worked on the perception of fatigue through age and time of diagnosis. For 
this reason, this study aims to verify the differences in the perceptions of fatigue between 
patients with FM between Brazil and in Portugal, as well as to evaluate and verify if there 
are differences in the perceptions of fatigue between the ages of the patients and the time 








Two independent samples were collected for the present study. Sample 1 consisted of 
290 Portuguese women, aged between 21 and 75 years (M = 47.44; SD = 10.73), invited 
to participate in the study. The Portuguese participants were diagnosed with FM in a 
physician who was 7.71 ± 6.04 years old. Sample 2 consisted of data from 429 Brazilian 
women aged between 18 and 77 years old (M = 46.52; SD = 9.23). Brazilian women were 
diagnosed with FM on average 7.86 ± 6.48 years. For the purpose of this study two-
groups in each sample were created: (a) diagnosis time, considering the media value for 
5 for the Portuguese samples and 6 for the Brazilian sample; (b) age-groups, considering 
the division into three groups, where group 1 had people with FM who were between 18 
and 29 years old, group 2 with 30 to 50 years old, and group 3 with over 51 years old. 
This was done based on the literature that says that middle-aged women, around 30 to 
50 years old, are the most affected by FM (Assumpcao et al., 2018; Saral et al., 2016). 
Data collect 
We contacted the doctors responsible for the specific FM groups on Facebook, so that 
they could forward and administer the questionnaires to members with FM. All 
individuals participated voluntarily in this study, receiving no monetary reward for their 
contribution. Before data collection, ethical approval was obtained from the ethical and 
scientific director of the Center for Research in Sport, Health and Human Development 
(CIDESD) under the reference UID04045 / 2020, Portugal. The current study was 
conducted in accordance with the Helsinki declaration and its latest amendments. 
Instrument 
For this study, MDF-fibro-17 validated for Brazilian and Portuguese populations was 
used (previously in Study 1) to measure the different components of FM-related fatigue. 
These 17 items consist of five subscales: global fatigue experience (four items; for 
example, "How severe was your fatigue today"); Physical fatigue (three items; for 
example, "How weak your muscles were today"); Cognitive fatigue (four items; for 
example, "How hard was it to concentrate because you were tired today?"); Motivation 
(three items; for example, "How much effort was made today?"); and Impact on function 
(three items; for example, "Did you do things more slowly because you were tired 





("nothing") to 10 ("extremely"). Higher scores indicated greater fatigue severity. Previous 
studies supported the validity and reliability of this questionnaire (Hudson et al., 2009). 
Statistical analysis 
Descriptive statistics, including means and standard deviation were calculated of all 
studied variables in two samples. Subsequently, a t-test for independent sample was used 
to analyze the difference between the perceptions of the fatigue domains among Brazilian 
and Portuguese individuals, as well as, between diagnoses time in each sample. In 
addition, one away ANOVA was performed to analyze the differences between the 
perceptions of the fatigue domains across different age-groups, as suggested by Ho 
(2014) (Ho, 2014) . For these analyses, a p-value ≤ .05 was adopted to reject the null 
hypothesis. Finally, Cohen d and partial eta square, respectively were calculated to test 
the effect size and the following cut-off values were assumed: trivial (0–.19), small (.20–
.49), medium (.50–.79) and large (.80 and greater) (Cohen, 2013). In case of differences 










A preliminary inspection of the data was performed, which showed no missing values or 
outliers. Skewness and kurtosis values are included in the cutoff points that do not reveal 
a violation of the univariate data distribution. 
Comparison of fatigue components between Brazil and 
Portugal 
The analysis of the t-test for independent samples showed that there are significant 
differences between the perception between Brazilians and Portuguese when asked 
about their perception of the components of fatigue (p <0.01). For detailed information 
see Tables 6 and 7. 
Table 6. Descriptive statistics between samples 
Note. N = samples size; M = mean; SD = Standard Deviation. 
 
Table 7. Comparison between the Brazil and Portugal samples in relation to the Fatigue domains 
  t df p-value 
Global Experience -3.690 717 <.001 
Physical Fatigue -5.898 717 <.001 
Cognitive Fatigue -4.848 717 <.001 
Motivation -5.312 717 <.001 
Impact on function -5.847 717 <.001 
Note. t= t test; df = degrees of freedom; p = level of significance.  
  
 
N M SD 
Global Experience Portugal 290 7.25 1.58 
Brasil 429 7.72 1.74 
Physical Fatigue Portugal 290 7.50 1.64 
Brasil 429 8.22 1.59 
Cognitive Fatigue Portugal 290 7.20 1.86 
Brasil 429 7.88 1.82 
Motivation Portugal 290 7.50 1.70 
Brasil 429 8.19 1.71 
Impact on function Portugal 290 7.45 1.83 





Analysis of age in relation to the perception of fatigue 
in the samples 
The age division was primarily divided into three groups, where group 1 (G1) had 
people with FM who were between 18 and 29 years old, group 2 (G2) with 30 to 50 
years old, and group 3 (G3) with over 51 years old. This was done based on the 
literature that says that middle-aged women, around 30 to 50 years old, are the most 
affected by FM. This was done, in tables 8 and 9, in order to verify if there are 
differences in the perception between the components of fatigue through the age of the 
patient with FM. 




Table 8. Descriptive statistics between the age groups of the Portuguese sample 
  G N M SD 
Global Experience G1 17 6.68 1.87 
  G2 158 7.26 1.57 
  G3 115 7.32 1.55 
  Total 290 7.25 1.58 
Physical Fatigue G1 17 7.02 2.30 
  G2 158 7.41 1.56 
  G3 115 7.69 1.62 
  Total 290 7.50 1.64 
Cognitive Fatigue G1 17 6.56 1.88 
  G2 158 7.21 1.78 
  G3 115 7.29 1.96 
  Total 290 7.21 1.86 
Motivation G1 17 6.74 1.41 
  G2 158 7.48 1.75 
  G3 115 7.65 1.66 
  Total 290 7.50 1.70 
Impact on function G1 17 6.50 2.53 
  G2 158 7.46 1.79 
  G3 115 7.57 1.75 





Table 9. Comparison between age groups for each fatigue factor in the Portuguese sample. 
   df p-value 
Global Experience Between groups 2 .291 
  In groups 287 
 
  Total 289 
 
Physical Fatigue Between groups 2 .184 
  In groups 287 
 
  Total 289 
 
Cognitive Fatigue Between groups 2 .315 
  In groups 287 
 
  Total 289 
 
Motivation Between groups 2 .119 
  In groups 287 
 
  Total 289 
 
Impact on function Between groups 2 .080 
  In groups 287 
 
  Total 289  
Note. df = Degrees of freedom; p = level of significance. 
 
Using the same criteria for dividing the groups, based on the age of patients with FM, in 
Tables 10 and11, the test was performed to verify the differences in perception between 





















Table 10. Descriptive statistics between the age groups of the Brazilian sample 
  G N M SD 
Global Experience G1 12 7.60 1.62 
  G2 267 7.80 1.73 
  G3 150 7.60 1.76 
  Total 429 7.72 1.74 
Physical Fatigue G1 12 7.80 1.39 
  G2 267 8.29 1.60 
  G3 150 8.12 1.57 
  Total 429 8.22 1.59 
Cognitive Fatigue G1 12 7.39 2.06 
  G2 267 8.05 1.78 
  G3 150 7.63 1.85 
  Total 429 7.88 1.82 
Motivation G1 12 7.75 1.84 
  G2 267 8.31 1.65 
  G3 150 8.01 1.79 
  Total 429 8.19 1.71 
Impact on function G1 12 8.05 1.91 
  G2 267 8.36 1.75 
  G3 150 8.11 1.89 





Table 11. Comparison between age groups for each fatigue factor in the Brazilian sample 
  df p 
Global Experience Between groups 2 .532 
 In groups 426 
 
 Total 428 
 
Physical Fatigue Between groups 2 .365 
 In groups 426 
 
 Total 428 
 
Cognitive Fatigue Between groups 2 .052 
 In groups 426 
 
 Total 428 
 
Motivation Between groups 2 .153 
 In groups 426 
 
 Total 428 
 
Impact on function Between groups 2 .379 
 In groups 426 
 
 Total 428  
Note: df = Degrees of freedom; p = level of significance. 
 
Analysis of diagnostic time in relation to the 
perception of fatigue in the samples 
To perform the analysis between the time of diagnosis (TD) and the fatigue components, 
a median of the values was performed in relation to the TD. For the Portuguese sample, 
the median value of 5. was obtained. With this we divided the samples into two large 
groups, where Group 1 (DTG 1) was the patients who had the diagnosis less than 5 years 
ago, and Group 2 (DTG 2) for the patients with a positive diagnosis. another 5 years. 
After performing this division between groups, tables 12 and 13 show the values obtained 












Table 12. Descriptive statistics between the age groups of the Portuguese sample 
  DTG N M SD 
Global Experience DTG 1 125 7.31 1.50 
DTG 2 165 7.20 1.65 
Physical Fatigue DTG 1 125 7.56 1.63 
DTG 2 165 7.45 1.65 
Cognitive Fatigue DTG 1 125 7.29 1.69 
DTG 2 165 7.14 1.98 
Motivation DTG 1 125 7.53 1.66 
DTG 2 165 7.48 1.73 
Impact on function DTG 1 125 7.57 1.74 
DTG 2 165 7.37 1.90 
Note. GTD - Diagnostic Time Group; N = number of patients; M = Mean; SD = Standard Deviation 
Table 13. Comparison between the time of diagnosis in relation to the fatigue domains in the Portuguese 
sample  
 t df p 
Global Experience .593 288 .554 
Physical Fatigue .576 288 .565 
Cognitive Fatigue .701 288 .484 
Motivation .237 288 .813 
Impact on function .945 288 .346 
Note. t= T test; df = degrees of freedom; p = level of significance. 
 
For the Brazilian sample, the median value was 6. Then, again we divided the samples 
into two large groups, where Group 1 (DTG 1) was the patients who had the diagnosis 
less than 6 years ago, and Group 2 (DTG 2) for the patients with diagnosis positive for 
another 6 years. After performing this division between groups, tables 14 and 15 show 









Table 14. Descriptive statistics between the age groups of the Brazilian sample 
Note. DTG - Diagnostic Time Group; N = number of patients; M = Mean; SD = Standard Deviation 
 
Table 15. Comparison between the time of diagnosis in relation to the fatigue domains in the Brazilian 
sample 
  t df p 
Global Experience .199 427 .842 
Physical Fatigue -.880 427 .379 
Cognitive Fatigue -.082 427 .935 
Motivation .059 427 .953 
Impact on function -.156 427 .876 
Note. t= T test; df = degrees of freedom; p = level of significance. 
 
  DTG N M SD 
Global Experience DTG 1 236 7.74 1.77 
DTG 2 193 7.70 1.71 
Physical Fatigue DTG 1 236 8.16 1.64 
DTG 2 193 8.29 1.52 
Cognitive Fatigue DTG 1 236 7.88 1.96 
DTG 2 193 7.89 1.64 
Motivation DTG 1 236 8.20 1.76 
DTG 2 193 8.19 1.65 
Impact on function DTG 1 236 8.25 1.90 






The aim of the present study was to address a gap in the literature, which was the 
verification and comparison of the perception of the 5 components of fatigue between 
two different cultures, just as the comparison was made through age and time of 
diagnosis. In general, the results confirmed that there are differences between the 
perception of fatigue components between Brazilians and Portuguese, however, unlike 
pain, fatigue proves to be a symptom that does not slow down with age and time of 
diagnosis. 
Comparison of fatigue components between Brazil and 
Portugal. 
The present results suggest that Brazilian women with FM, when compared to 
Portuguese women, tend to have a more pronounced perception of the components of 
fatigue, as can be seen by the mean values in table 1 and the significance in table 2 (p 
<.001). This can demonstrate that different populations, with different cultures, can 
demonstrate different perceptions of fatigue in relation to the disease. 
One of the factors that can explain this difference in the perception of fatigue between 
cultures is the level of physical activity. McLoughlin et al (McLoughlin, Stegner, & Cook, 
2011), reported that individuals who performed regular physical activities had better 
parameters for modulation and control of pain in FM. However, according to data from 
Eurobarometer (2018), Portugal had a 68% rate of physical inactivity among its 
population, while Brazil has a 62% rate of physical inactivity, according to the Brazilian 
Institute of Geography and Statistics (IBGE, 2015). This demonstrates that physical 
activity is beneficial for pain control, however, in the context of fatigue, the same, if not 
performed in a controlled manner or accompanied by a specialist, can cause an increase 
in the perception of fatigue in patients with FM. 
Another factor that may explain these differences between perceptions of fatigue 
among Brazilian and Portuguese, is that Brazil, having a greater geographical proportion, 
ends up having different social realities between states and regions, which ends up 
causing social inequalities, with that, it ends up for making it difficult to access the 
complex diagnosis of the disease and its pharmacological and non-pharmacological 
treatments (Souza & Perissinotti, 2018). Future research aimed at checking the level of 





would help to clarify whether physical activity in a controlled and monitored manner 
improves fatigue levels. 
Analysis of age in relation to the perception of fatigue 
in the samples 
The results of this study showed that fatigue components are not significant in age 
groups, regardless of the cultural sample analyzed, as demonstrated by the values shown 
in tables 4 and 6 (p> .050). This demonstrates that fatigue, and its components, tend to 
be relevant symptoms and that they deteriorate the quality of life of FM patients, 
regardless of their age. This finding differs from studies by Burckhardt (Burckhardt et 
al., 2010), Kennedy (Kennedy & Felson, 1996) and Granges (Granges et al., 1994), who 
indicated that pain tends to decrease over the years. This may reveal that fatigue is the 
most persistent symptom and that there is no slowing down over the years in FM 
patients. 
Analysis of diagnostic time in relation to the 
perception of fatigue in the samples 
When comparing the perception of fatigue domains and the time of diagnosis, we 
found that there are no significant differences, as can be analyzed in tables 8 and 10 (p> 
0.050). That is, regardless of the time the patient has a positive diagnosis, fatigue and its 
components, it continues to be felt over time. This result confronts the study by Berber 
et al (Berber et al., 2005), which demonstrated that the longer the time of diagnosis, the 








The present findings showed that despite the difference between the perception of 
fatigue between Brazilian and Portuguese, there are no significant differences between 
the components of fatigue over the years and the time of diagnosis. This shows that 
fatigue is the symptom that persists the most during the disease. However, the current 
findings must be considered in relation to some limitations. First, this survey did not 
directly measure the level of physical activity among the participants. This fact can be 
explored in future research to verify which physical activity or exercise improves the 
components of fatigue. Second, the findings of this study cannot be used for comparison 
between other cultures, as more research is needed to establish this comparative pattern. 
So future studies should examine these parameters in other groups with cultural 
differences. 
Practical implications 
The analysis of the perception of the components of fatigue in comparison between 
cultures, and through the age and time of diagnosis bring significant contributions to the 
literature in the scope of FM. These findings complement the limited literature regarding 
FM fatigue. The present study reinforces the real importance of assessing fatigue in 
patients with FM, as it is an extremely relevant symptom, regardless of the time of 












Analyzing the main objectives of this thesis, in relation to our review of the literature, 
translation and validation of the questionnaire, the results can be summarized in the 
following points: 
i) The review showed several gaps in the literature, specifically with regard to 
investigations on the effects of fatigue and its components in patients with FM. 
ii) The translated and validated scales can be used with a high degree of reliability and 
validity in FM patients, checking the 5 components of fatigue. 
iii) the theoretical model of the MDF-fibro-17 is the same for both countries (configural 
invariance) and the factorial weight of the items is equivalent for both countries 
(invariance of the measure), that is, each item has the same importance regardless of the 
group. 
iv) The level of perception of fatigue among FM patients is high, showing that this 
symptom is extremely relevant to their patients and their well-being. However, when 
comparing this perception between cultures, it appears that Brazilian women tend to 
have more problems than Portuguese women; 
v) There is no significant difference in relation to the perception of fatigue, even at older 
ages, as at younger ages, which shows that fatigue is equally debilitating at any age of the 
patient. 
vi) As with age, the time of diagnosis did not show a significant difference when 
comparing patients with recent diagnosis with patients with older diagnosis. Which also 
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5) Quanto enfraquecidos sentiu os seus músculos hoje? 



































































































17) Fez algo mais devagar porque estava a sentir-se cansado(a) 












Cidade onde Reside: 
Tempo de Diagnostico: 
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